FDA chief exits after vape approval clash

Marty Makary has resigned as Food and Drug Administration commissioner after weeks of pressure, thrusting the agency into fresh turmoil over one of its most politically charged decisions.

Reports indicate Makary privately opposed the administration’s decision to approve flavored vapes, a split that appears to have widened into a breaking point. The departure leaves the FDA facing a leadership shakeup at a moment when its credibility and independence already sit under intense scrutiny. The agency’s top food official will step into the role, according to the news signal, placing a senior insider at the center of an escalating policy fight.

Makary’s exit underscores how quickly a policy dispute can become a power struggle at the top of a major health regulator.

The clash matters because flavored vape policy sits at the intersection of public health, industry pressure, and White House politics. Any sign that internal dissent played a role in the commissioner’s departure will raise new questions about how major regulatory calls get made. It also puts a spotlight on whether agency leaders can challenge politically sensitive decisions without risking their positions.

For now, the immediate consequence is instability at one of the government’s most consequential watchdogs. Staff, companies, and public health advocates will watch closely for signals from the incoming acting leader about whether the agency stays the course or shifts direction. What happens next will shape not just vape oversight, but confidence in how the FDA makes contested decisions when political pressure closes in.